메뉴 건너뛰기




Volumn 32, Issue 4, 2010, Pages 512-516

Enantioselective assay for therapeutic drug monitoring of eslicarbazepine acetate: No interference with carbamazepine and its metabolites

Author keywords

carbamazepine; enantioselective HPLC method; eslicarbazepine acetate; licarbazepine enantiomers; therapeutic drug monitoring

Indexed keywords

CARBAMAZEPINE; ESLICARBAZEPINE ACETATE; ANTICONVULSIVE AGENT; DIBENZAZEPINE DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

EID: 77955173774     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181e5c855     Document Type: Article
Times cited : (11)

References (24)
  • 1
    • 33746124186 scopus 로고    scopus 로고
    • ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
    • Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094-1120.
    • (2006) Epilepsia , vol.47 , pp. 1094-1120
    • Glauser, T.1    Ben-Menachem, E.2    Bourgeois, B.3
  • 2
    • 10044228160 scopus 로고    scopus 로고
    • Therapeutic drug monitoring of old and newer antiepileptic drugs
    • Neels HM, Sierens AC, Naelaerts K, et al. Therapeutic drug monitoring of old and newer antiepileptic drugs. Clin Chem Lab Med. 2004;42: 1228-1255.
    • (2004) Clin Chem Lab Med , vol.42 , pp. 1228-1255
    • Neels, H.M.1    Sierens, A.C.2    Naelaerts, K.3
  • 3
    • 33745251005 scopus 로고    scopus 로고
    • New antiepileptic drugs that are second generation to existing antiepileptic drugs
    • Bialer M. New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opin Investig Drugs. 2006;15:637-647.
    • (2006) Expert Opin Investig Drugs , vol.15 , pp. 637-647
    • Bialer, M.1
  • 4
    • 34547828792 scopus 로고    scopus 로고
    • Development of new antiepileptic drugs: Challenges, incentives, and recent advances
    • Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol. 2007;6: 793-804.
    • (2007) Lancet Neurol , vol.6 , pp. 793-804
    • Perucca, E.1    French, J.2    Bialer, M.3
  • 6
    • 0032420869 scopus 로고    scopus 로고
    • Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta
    • Myllynen P, Pienimäki P, Raunio H, et al. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta. Hum Exp Toxicol. 1998;17:668-676.
    • (1998) Hum Exp Toxicol , vol.17 , pp. 668-676
    • Myllynen, P.1    Pienimäki, P.2    Raunio, H.3
  • 7
    • 1842739967 scopus 로고    scopus 로고
    • Overview of the clinical pharmacokinetics of oxcarbazepine
    • Flesch G. Overview of the clinical pharmacokinetics of oxcarbazepine. Clin Drug Invest. 2004;24:185-203.
    • (2004) Clin Drug Invest , vol.24 , pp. 185-203
    • Flesch, G.1
  • 8
    • 0030199560 scopus 로고    scopus 로고
    • Dose-dependent metabolism of carbamazepine in humans
    • Bernus I, Dickinson RG, Hooper WD, et al. Dose-dependent metabolism of carbamazepine in humans. Epilepsy Res. 1996;24:163-172.
    • (1996) Epilepsy Res , vol.24 , pp. 163-172
    • Bernus, I.1    Dickinson, R.G.2    Hooper, W.D.3
  • 10
    • 0026722774 scopus 로고
    • A new carbamazepine metabolite in uraemic filtrate
    • Beyer C, Spiteller G. A new carbamazepine metabolite in uraemic filtrate. Xenobiotica. 1992;22:1029-1035.
    • (1992) Xenobiotica , vol.22 , pp. 1029-1035
    • Beyer, C.1    Spiteller, G.2
  • 11
    • 61849168486 scopus 로고    scopus 로고
    • Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study
    • Elger C, Halász P, Maia J, et al. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia. 2009;50:454-463.
    • (2009) Epilepsia , vol.50 , pp. 454-463
    • Elger, C.1    Halász, P.2    Maia, J.3
  • 12
    • 70349972675 scopus 로고    scopus 로고
    • Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures
    • Gil-Nagel A, Lopes-Lima J, Almeida L, et al. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand. 2009;120:281-287.
    • (2009) Acta Neurol Scand , vol.120 , pp. 281-287
    • Gil-Nagel, A.1    Lopes-Lima, J.2    Almeida, L.3
  • 13
    • 71949118429 scopus 로고    scopus 로고
    • Efficacy and safety of eslicarbazepine acetate (ESL) as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-302 study
    • Ben-Menachem E, Gabbai AA, Hufnagel A, et al. Efficacy and safety of eslicarbazepine acetate (ESL) as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-302 study. Epilepsia. 2008;49(Suppl 7): 424-425.
    • (2008) Epilepsia , vol.49 , Issue.SUPPL. 7 , pp. 424-425
    • Ben-Menachem, E.1    Gabbai, A.A.2    Hufnagel, A.3
  • 14
    • 77952746618 scopus 로고    scopus 로고
    • Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): Results of one-year open-label extension of study BIA-2093-302
    • Gabbai AA, Ben-Menachem E, Maia J, et al. Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): results of one-year open-label extension of study BIA-2093-302. Epilepsia. 2008;49(Suppl 7):432.
    • (2008) Epilepsia , vol.49 , Issue.SUPPL. 7 , pp. 432
    • Gabbai, A.A.1    Ben-Menachem, E.2    Maia, J.3
  • 15
    • 77951459542 scopus 로고    scopus 로고
    • Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): Results of one-year open-label extension to study BIA-2093-301
    • Halász P, Elger C, Guekht, et al. Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): results of one-year open-label extension to study BIA-2093-301. Epilepsia. 2008;49(Suppl 7):436.
    • (2008) Epilepsia , vol.49 , Issue.SUPPL. 7 , pp. 436
    • Halász, P.1    Guekht, E.C.2
  • 16
    • 77955175580 scopus 로고    scopus 로고
    • Efficacy and safety of eslicarbazepine acetate as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-301 study
    • Elger C, Halasz P, Maia J, et al. Efficacy and safety of eslicarbazepine acetate as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-301 study. Epilepsia. 2009;50(Suppl 4):71.
    • (2009) Epilepsia , vol.50 , Issue.SUPPL. 4 , pp. 71
    • Elger, C.1    Halasz, P.2    Maia, J.3
  • 17
    • 77955170803 scopus 로고    scopus 로고
    • Efficacy and safety of eslicarbazepine acetate as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-302 study
    • Hufnagel A, Ben-Menachem E, Gabbai AA, et al. Efficacy and safety of eslicarbazepine acetate as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-302 study. Epilepsia. 2009;50(Suppl 4):104.
    • (2009) Epilepsia , vol.50 , Issue.SUPPL. 4 , pp. 104
    • Hufnagel, A.1    Ben-Menachem, E.2    Gabbai, A.A.3
  • 18
    • 77955177172 scopus 로고    scopus 로고
    • Efficacy and safety of esli-carbazepine acetate as add-on treatment in adults with refractory partial-onset seizures BIA-2093-303 study
    • Lopes-Lima J, Gil-Nagel A, Maia J, et al. Efficacy and safety of esli-carbazepine acetate as add-on treatment in adults with refractory partial-onset seizures BIA-2093-303 study. Epilepsia. 2009;50(Suppl 4):106.
    • (2009) Epilepsia , vol.50 , Issue.SUPPL. 4 , pp. 106
    • Lopes-Lima, J.1    Gil-Nagel, A.2    Maia, J.3
  • 19
    • 77955175684 scopus 로고    scopus 로고
    • An investigation of the effect of eslicarbazepine acetate on the pharmacokinetics of carbamazepine: A pooled analysis of three placebo-controlled phase III clinical studies
    • Maia J, Versavel M, Nunes T, et al. An investigation of the effect of eslicarbazepine acetate on the pharmacokinetics of carbamazepine: a pooled analysis of three placebo-controlled phase III clinical studies. Epilepsia. 2009;50(Suppl 11):118-119.
    • (2009) Epilepsia , vol.50 , Issue.SUPPL. 11 , pp. 118-119
    • Maia, J.1    Versavel, M.2    Nunes, T.3
  • 20
    • 77951455955 scopus 로고    scopus 로고
    • An investigation of the therapeutic effect of eslicarbazepine acetate combined with carbamazepine: Pooled analysis of three placebo-controlled phase III clinical studies
    • Soares-da-Silva P, Versavel M, Nunes T, et al. An investigation of the therapeutic effect of eslicarbazepine acetate combined with carbamazepine: pooled analysis of three placebo-controlled phase III clinical studies. Epilepsia. 2009;50(Suppl 11):122-123.
    • (2009) Epilepsia , vol.50 , Issue.SUPPL. 11 , pp. 122-123
    • Soares-Da-Silva, P.1    Versavel, M.2    Nunes, T.3
  • 21
    • 33750366552 scopus 로고    scopus 로고
    • Pharmacokinetic variability of newer anti-epileptic drugs: When is monitoring needed?
    • Johannessen SI, Tomson T. Pharmacokinetic variability of newer anti-epileptic drugs: when is monitoring needed? Clin Pharmacokinet. 2006; 45:1061-1075.
    • (2006) Clin Pharmacokinet , vol.45 , pp. 1061-1075
    • Johannessen, S.I.1    Tomson, T.2
  • 22
    • 36749058390 scopus 로고    scopus 로고
    • Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma
    • Alves G, Figueiredo I, Castel-Branco M, et al. Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma. Biomed Chromatogr. 2007;21: 1127-1134.
    • (2007) Biomed Chromatogr , vol.21 , pp. 1127-1134
    • Alves, G.1    Figueiredo, I.2    Castel-Branco, M.3
  • 23
    • 34547193773 scopus 로고    scopus 로고
    • Stereoselectivity in drug metabolism
    • Lu H. Stereoselectivity in drug metabolism. Expert Opin Drug Metab Toxicol. 2007;3:149-158.
    • (2007) Expert Opin Drug Metab Toxicol , vol.3 , pp. 149-158
    • Lu, H.1
  • 24
    • 0033391871 scopus 로고    scopus 로고
    • Enantioselective pharmaco-kinetics of 10-hydroxycarbazepine after oral administration of oxcarba-zepine to healthy Chinese subjects
    • Volosov A, Xiaodong S, Perucca E, et al. Enantioselective pharmaco-kinetics of 10-hydroxycarbazepine after oral administration of oxcarba-zepine to healthy Chinese subjects. Clin Pharmacol Ther. 1999;66: 547-553.
    • (1999) Clin Pharmacol Ther , vol.66 , pp. 547-553
    • Volosov, A.1    Xiaodong, S.2    Perucca, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.